|4Dec 18, 5:00 PM ET

Buckbee Kevin K 4

4 · AbbVie Inc. · Filed Dec 18, 2024

Insider Transaction Report

Form 4
Period: 2024-12-16
Buckbee Kevin K
SVP, CONTROLLER
Transactions
  • Exercise/Conversion

    Option (Right to buy)

    2024-12-16$93.50/sh1,800$168,30012,111 total
    Exercise: $93.50From: 2021-02-20Exp: 2030-02-19Common Stock (1,800 underlying)
  • Exercise/Conversion

    Common Stock, $0.01 par value

    2024-12-16$93.50/sh+1,800$168,3008,783 total
  • Sale

    Common Stock, $0.01 par value

    2024-12-16$172.24/sh1,800$310,0326,983 total
Footnotes (1)
  • [F1]Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Documents

1 file
  • 4
    form4-12182024_051202.xmlPrimary